-
Signature
-
/s/ Keely Stewart, under Power of Attorney dated April 17, 2023, from William Meaney
-
Issuer symbol
-
IRM
-
Transactions as of
-
04 Oct 2023
-
Transactions value $
-
-$1,209,881
-
Form type
-
4
-
Filing time
-
06 Oct 2023, 16:08:04 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IRM |
Common Stock, par value $.01 per share |
Options Exercise |
$325,769 |
+10,507 |
+3.6% |
$31 |
306,157 |
04 Oct 2023 |
Direct |
|
| transaction |
IRM |
Common Stock, par value $.01 per share |
Sale |
-$603,837 |
-10,507 |
-3.4% |
$57.47 |
295,650 |
04 Oct 2023 |
Direct |
|
| transaction |
IRM |
Common Stock, par value $.01 per share |
Options Exercise |
$325,769 |
+10,507 |
+3.6% |
$31 |
306,157 |
05 Oct 2023 |
Direct |
|
| transaction |
IRM |
Common Stock, par value $.01 per share |
Sale |
-$606,043 |
-10,507 |
-3.4% |
$57.68 |
295,650 |
05 Oct 2023 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$325,769 |
-10,507 |
-17% |
$31 |
52,535 |
04 Oct 2023 |
Common Stock |
10,507 |
$31 |
Direct |
F1 |
| transaction |
IRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$325,769 |
-10,507 |
-20% |
$31 |
42,028 |
05 Oct 2023 |
Common Stock |
10,507 |
$31 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: